| | | Human | critically ill patients | Daily consumption (exact dosage not specified). | Impact of a novel nutritional formula on asthma control and biomarkers of allergic airway inflammation in children. |
| | | Human | patients with type 2 diabetes mellitus | Not specified | Potential Benefits of Antioxidant Phytochemicals in Type 2 Diabetes. |
| | | Human | — | Not specified | Oxidative stress and post-stroke depression: possible therapeutic role of polyphenols? |
| | | Human | null | Not specified. | Comprehensive and critical view on the anti-inflammatory and immunomodulatory role of natural phenolic antioxidants. |
| | | Human | null | Not specified. | Comprehensive and critical view on the anti-inflammatory and immunomodulatory role of natural phenolic antioxidants. |
| | | Human | null | Not specified. | Comprehensive and critical view on the anti-inflammatory and immunomodulatory role of natural phenolic antioxidants. |
| | | Human | — | Not specified | Dermocosmetic management of hyperpigmentations. |
| | | Human | cells | Not specified | Antioxidants for prostate cancer chemoprevention: challenges and opportunities. |
| | | HumanMolecular | endothelial cells | — | Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction. |
| | | Human | — | Not specified | Systemic antioxidants and skin health. |
| | | Human | — | Not specified | Dietary interventions in asthma. |
| | | Human | — | Not specified | The role of inflammatory biomarkers in developing targeted cardiovascular therapies: lessons from the cardiovascular inflammation reduction trials. |
| | | Human | patients with COPD | Not specified | The genomic landscape of chronic obstructive pulmonary disease: Insights from nutrigenomics. |
| | | Human | — | Not specified | Encapsulation of antioxidants in gastrointestinal-resistant nanoparticulate carriers. |
| | | Human | — | Not specified | Diabetes and the associated complications: The role of antioxidants in diabetes therapy and care. |
| | | Human | experimental models of MS | Not specified | Antioxidant Therapies in the Treatment of Multiple Sclerosis. |
| | | Human | — | Not specified | Guardians of Oral Health: Antioxidants as Promising Allies in Periodontal Wellness. |
| | | Human | — | Not specified | Targeting Metabolic Diseases: The Role of Nutraceuticals in Modulating Oxidative Stress and Inflammation. |
| | | Human | patients with NAFLD | Not specified | Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease. |
| | | Human | chronic pancreatitis patients | — | Antioxidants are not useful in reducing both pain and inflammation in chronic pancreatitis. |
| | | Human | chronic pancreatitis patients | — | Antioxidants are not useful in reducing both pain and inflammation in chronic pancreatitis. |
| | | Human | adults and adolescents with asthma | Not specified | Effect of dietary interventions on markers of type 2 inflammation in asthma: A systematic review. |
| | | Human | — | Not specified | Lecithinized superoxide dismutase in the past and in the present: Any role in the actual pandemia of COVID-19? |
| | | Molecular | — | Not specified | Optimized and comparative antioxidant assays and its applications in herbal and synthetic drug analysis as an antioxidants. |
| | | HumanMolecular | — | Not specified | Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants. |
| | | Human | — | Not specified (dietary intake, not isolated supplement). | An oral health optimized diet can reduce gingival and periodontal inflammation in humans - a randomized controlled pilot study. |
| | | Human | experimental models | Not specified | Hepatocellular Interactions of Potential Nutraceuticals in the Management of Inflammatory NAFLD. |
| | | Human | patients with DEDs or primary open-angle glaucoma | — | Patients undergoing long-term treatment with antihypertensive eye drops responded positively with respect to their ocular surface disorder to oral supplementation with antioxidants and essential fatty acids. |
| | | Human | — | Not specified | Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations. |
| | | Human | — | Not specified | The Role of Oxidative Stress and Antioxidants in Liver Diseases. |
| | | Human | — | Not specified | From Evidence to Practice: A Narrative Framework for Integrating the Mediterranean Diet into Inflammatory Bowel Disease Management. |
| | | Human | — | Not specified | Pancreatic Ductal Adenocarcinoma and Nutrition: Exploring the Role of Diet and Gut Health. |
| | | Human | adults | Not specified | Nutritional immunomodulation in critically ill children with acute lung injury: feasibility and impact on circulating biomarkers. |
| | | Human | — | Not specified | Antioxidants and neurodegenerative eye disease. |
| | | Human | patients with CP | Daily combined antioxidants (specific amounts not detailed) | Antioxidants for Pancreatic Functions in Chronic Pancreatitis: A Double-blind Randomized Placebo-controlled Pilot Study. |
| | | Human | elite athletes | Not specified | Mechanisms and management of exercise-induced asthma in elite athletes. |
| | | HumanAnimal | — | Not specified | Oxidative and Inflammatory Events in Prion Diseases: Can They Be Therapeutic Targets? |
| | | Human | — | Not specified | Hyperuricemia and Atrial Fibrillation. |
| | | Molecular | — | — | New insights into antioxidant strategies against paraquat toxicity. |
| | | Human | — | Not specified | Facial rejuvenation: combining cosmeceuticals with cosmetic procedures. |
| | | Human | skin | Not specified | Quercetin topical application, from conventional dosage forms to nanodosage forms. |
